Jubilant Pharmova gained 4.53% to Rs 702 after Jubilant Generics received a communication from the US drug regulator, which determined the inspection classification of its Roorkee facility as ‘Voluntary Action Indicated (VAI)’.
| Subscribe To Our Free Newsletter |
